Stock Price
23.57
Daily Change
0.70 3.06%
Monthly
17.79%
Yearly
-44.25%
Q3 Forecast
22.68

Celldex Therapeutics reported $-56600000 in Pre-Tax Profit for its fiscal quarter ending in June of 2025.




Pre Tax Profit Change Date
AbbVie USD 1.66B 3.15B Mar/2025
Amgen USD 1.57B 405M Jun/2025
Bristol-Myers Squibb USD 1.77B 1.2B Jun/2025
Celldex Therapeutics USD -56600000 2.8M Jun/2025
Glaxosmithkline GBP 1.89B 230.76M Jun/2025
Pfizer USD 3.04B 259M Jun/2025
Roche Holding CHF 1.78B 2.33B Dec/2024